Overview
David Liebovitz is a primary care provider, practicing in Internal Medicine in Chicago, Illinois. He has been practicing medicine for over 36 years.
Dr. Liebovitz is highly rated in 1 condition, according to our data. His clinical expertise encompasses Long Haul COVID, COVID-19, Thrombophlebitis, and Cerebral Hypoxia.
Dr. Liebovitz is board certified in American Board Of Internal Medicine - Internal Medicine (Certified). He is actively involved in clinical research, co-authoring 70 peer reviewed articles and participating in 1 clinical trial.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
- MEDICARE MAPD
- MEDICARE SNP
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
University Of Illinois Hospital
Robert Molokie is an Internal Medicine provider practicing medicine in Chicago, Illinois. Dr. Molokie is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Bone Marrow Transplant.
Endeavor Health Medical Group
Alfonso Tafur, MD, a cardiologist and director of vascular medicine services at Endeavor Health, specializes in managing blood clot disorders and vascular disease. He provides personalized, continuing care while leading research to improve treatment options for complex conditions. Dr. Tafur listens closely to understand each patient’s experience and works to guide them through every phase of their healthcare journey with compassion and precision. Dr. Tafur is highly rated in 41 conditions, according to our data. His clinical expertise encompasses Venous Thromboembolism (VTE), Pulmonary Embolism, Deep Vein Thrombosis, Hepato-Pancreato-Biliary Surgery, and Knee Replacement. Dr. Tafur is board certified in American Board Of Internal Medicine.
Comer Children's Hospital
Rima Mcleod is an Internal Medicine provider practicing medicine in Chicago, Illinois. Dr. Mcleod is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Toxoplasmosis, Congenital Toxoplasmosis, and Primary Amebic Meningoencephalitis.
Frequently Asked Questions about Dr. David M. Liebovitz
How do I make an appointment with Dr. David M. Liebovitz?
You can book an appointment with Dr. David M. Liebovitz by calling their office at 312-695-8630. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. David M. Liebovitz a top-rated expert for Long Haul COVID?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. David M. Liebovitz is classified as an Advanced expert for Long Haul COVID, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. David M. Liebovitz specialize in?
While Dr. David M. Liebovitz is a Internal Medicine, they have specific expertise in Long Haul COVID, COVID-19, and Thrombophlebitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.
Does Dr. David M. Liebovitz participate in research or clinical trials?
Yes. Dr. David M. Liebovitz has published 70 articles and abstracts on conditions like Long Haul COVID. You can view a list of Dr. David M. Liebovitz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. David M. Liebovitz accept my insurance?
Dr. David M. Liebovitz accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 312-695-8630 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Long Haul COVIDDr. Liebovitz isAdvanced. Learn about Long Haul COVID.
- Experienced
- Acute PainDr. Liebovitz isExperienced. Learn about Acute Pain.
- AtherosclerosisDr. Liebovitz isExperienced. Learn about Atherosclerosis.
- Cerebral HypoxiaDr. Liebovitz isExperienced. Learn about Cerebral Hypoxia.
- Chronic CoughDr. Liebovitz isExperienced. Learn about Chronic Cough.
- Colorectal CancerDr. Liebovitz isExperienced. Learn about Colorectal Cancer.
- COVID-19Dr. Liebovitz isExperienced. Learn about COVID-19.